8-Oxoguanine DNA glycosylase-1-driven DNA base excision repair: Role in asthma pathogenesis

Xueqing Ba, Leopoldo Aguilera-Aguirre, Sanjiv Sur, Istvan Boldogh

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose of Review: To provide both an overview and evidence of the potential cause of oxidative DNA base damage and repair signaling in chronic inflammation and histological changes associated with asthma. Recent Findings: Asthma is initiated/maintained by immunological, genetic/epigenetic, and environmental factors. It is a world-wide health problem, as current therapies suppress symptoms rather than prevent/reverse the disease, largely due to gaps in understanding its molecular mechanisms. Inflammation, oxidative stress, and DNA damage are inseparable phenomena, but their molecular roles in asthma pathogenesis are unclear. It was found that among oxidatively modified DNA bases, 8-oxoguanine (8-oxoG) is one of the most abundant, and its levels in DNA and body fluids are considered a biomarker of ongoing asthmatic processes. Free 8-oxoG forms a complex with 8-oxoG DNA glycosylase-1 and activates RAS-family GTPases that induce gene expression to mobilize innate and adaptive immune systems, along with genes regulating airway hyperplasia, hyper-responsiveness, and lung remodeling in atopic and nonatopic asthma. Summary: DNA's integrity must be maintained to prevent mutation, so its continuous repair and downstream signaling 'fuel' chronic inflammatory processes in asthma and form the basic mechanism whose elucidation will allow the development of new drug targets for the prevention/reversal of lung diseases.

Original languageEnglish
Pages (from-to)89-97
Number of pages9
JournalCurrent Opinion in Allergy and Clinical Immunology
Volume15
Issue number1
DOIs
StatePublished - Feb 13 2015

Fingerprint

DNA Glycosylases
DNA Repair
Asthma
DNA
DNA Damage
Respiratory Hypersensitivity
Inflammation
GTP Phosphohydrolases
Body Fluids
Epigenomics
Lung Diseases
Hyperplasia
Immune System
Oxidative Stress
Biomarkers
8-hydroxyguanine
Gene Expression
Lung
Mutation
Pharmaceutical Preparations

Keywords

  • 8-oxoguanine
  • 8-oxoguanine DNA glycosylase-1
  • asthma
  • DNA repair
  • inflammation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

8-Oxoguanine DNA glycosylase-1-driven DNA base excision repair : Role in asthma pathogenesis. / Ba, Xueqing; Aguilera-Aguirre, Leopoldo; Sur, Sanjiv; Boldogh, Istvan.

In: Current Opinion in Allergy and Clinical Immunology, Vol. 15, No. 1, 13.02.2015, p. 89-97.

Research output: Contribution to journalArticle

@article{1529af00211d4a3ab704bfeb3ad4b1e7,
title = "8-Oxoguanine DNA glycosylase-1-driven DNA base excision repair: Role in asthma pathogenesis",
abstract = "Purpose of Review: To provide both an overview and evidence of the potential cause of oxidative DNA base damage and repair signaling in chronic inflammation and histological changes associated with asthma. Recent Findings: Asthma is initiated/maintained by immunological, genetic/epigenetic, and environmental factors. It is a world-wide health problem, as current therapies suppress symptoms rather than prevent/reverse the disease, largely due to gaps in understanding its molecular mechanisms. Inflammation, oxidative stress, and DNA damage are inseparable phenomena, but their molecular roles in asthma pathogenesis are unclear. It was found that among oxidatively modified DNA bases, 8-oxoguanine (8-oxoG) is one of the most abundant, and its levels in DNA and body fluids are considered a biomarker of ongoing asthmatic processes. Free 8-oxoG forms a complex with 8-oxoG DNA glycosylase-1 and activates RAS-family GTPases that induce gene expression to mobilize innate and adaptive immune systems, along with genes regulating airway hyperplasia, hyper-responsiveness, and lung remodeling in atopic and nonatopic asthma. Summary: DNA's integrity must be maintained to prevent mutation, so its continuous repair and downstream signaling 'fuel' chronic inflammatory processes in asthma and form the basic mechanism whose elucidation will allow the development of new drug targets for the prevention/reversal of lung diseases.",
keywords = "8-oxoguanine, 8-oxoguanine DNA glycosylase-1, asthma, DNA repair, inflammation",
author = "Xueqing Ba and Leopoldo Aguilera-Aguirre and Sanjiv Sur and Istvan Boldogh",
year = "2015",
month = "2",
day = "13",
doi = "10.1097/ACI.0000000000000135",
language = "English",
volume = "15",
pages = "89--97",
journal = "Current Opinion in Allergy and Clinical Immunology",
issn = "1528-4050",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - 8-Oxoguanine DNA glycosylase-1-driven DNA base excision repair

T2 - Role in asthma pathogenesis

AU - Ba, Xueqing

AU - Aguilera-Aguirre, Leopoldo

AU - Sur, Sanjiv

AU - Boldogh, Istvan

PY - 2015/2/13

Y1 - 2015/2/13

N2 - Purpose of Review: To provide both an overview and evidence of the potential cause of oxidative DNA base damage and repair signaling in chronic inflammation and histological changes associated with asthma. Recent Findings: Asthma is initiated/maintained by immunological, genetic/epigenetic, and environmental factors. It is a world-wide health problem, as current therapies suppress symptoms rather than prevent/reverse the disease, largely due to gaps in understanding its molecular mechanisms. Inflammation, oxidative stress, and DNA damage are inseparable phenomena, but their molecular roles in asthma pathogenesis are unclear. It was found that among oxidatively modified DNA bases, 8-oxoguanine (8-oxoG) is one of the most abundant, and its levels in DNA and body fluids are considered a biomarker of ongoing asthmatic processes. Free 8-oxoG forms a complex with 8-oxoG DNA glycosylase-1 and activates RAS-family GTPases that induce gene expression to mobilize innate and adaptive immune systems, along with genes regulating airway hyperplasia, hyper-responsiveness, and lung remodeling in atopic and nonatopic asthma. Summary: DNA's integrity must be maintained to prevent mutation, so its continuous repair and downstream signaling 'fuel' chronic inflammatory processes in asthma and form the basic mechanism whose elucidation will allow the development of new drug targets for the prevention/reversal of lung diseases.

AB - Purpose of Review: To provide both an overview and evidence of the potential cause of oxidative DNA base damage and repair signaling in chronic inflammation and histological changes associated with asthma. Recent Findings: Asthma is initiated/maintained by immunological, genetic/epigenetic, and environmental factors. It is a world-wide health problem, as current therapies suppress symptoms rather than prevent/reverse the disease, largely due to gaps in understanding its molecular mechanisms. Inflammation, oxidative stress, and DNA damage are inseparable phenomena, but their molecular roles in asthma pathogenesis are unclear. It was found that among oxidatively modified DNA bases, 8-oxoguanine (8-oxoG) is one of the most abundant, and its levels in DNA and body fluids are considered a biomarker of ongoing asthmatic processes. Free 8-oxoG forms a complex with 8-oxoG DNA glycosylase-1 and activates RAS-family GTPases that induce gene expression to mobilize innate and adaptive immune systems, along with genes regulating airway hyperplasia, hyper-responsiveness, and lung remodeling in atopic and nonatopic asthma. Summary: DNA's integrity must be maintained to prevent mutation, so its continuous repair and downstream signaling 'fuel' chronic inflammatory processes in asthma and form the basic mechanism whose elucidation will allow the development of new drug targets for the prevention/reversal of lung diseases.

KW - 8-oxoguanine

KW - 8-oxoguanine DNA glycosylase-1

KW - asthma

KW - DNA repair

KW - inflammation

UR - http://www.scopus.com/inward/record.url?scp=84920869940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920869940&partnerID=8YFLogxK

U2 - 10.1097/ACI.0000000000000135

DO - 10.1097/ACI.0000000000000135

M3 - Article

C2 - 25486379

AN - SCOPUS:84920869940

VL - 15

SP - 89

EP - 97

JO - Current Opinion in Allergy and Clinical Immunology

JF - Current Opinion in Allergy and Clinical Immunology

SN - 1528-4050

IS - 1

ER -